INTRAGASTRIC BALLOON AND IMPACT ON WEIGHT LOSS: EXPERIENCE IN QUITO, EQUADOR

被引:2
|
作者
Jerez, Jonathan [1 ]
Cabrera, David [1 ]
Cisneros, Carlos [1 ]
Moreno, Monica [1 ]
Guaitara, Daniela [1 ]
Benavides, Chiristian [1 ]
Fors, Martha [2 ]
Falcon, Kirsten [3 ]
机构
[1] SOMClin, Gastroenterol, Quito, Ecuador
[2] Univ Amer, Fac Hlth Sci, Quito, Ecuador
[3] Univ Sao Paulo, Sao Paulo, SP, Brazil
来源
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY | 2023年 / 36卷 / 01期
关键词
Endoscopy; Body mass index; Digestive system; Body weight; Obesity; OBESITY; INDIVIDUALS; MANAGEMENT; REDUCTION; EFFICACY; THERAPY; TERM;
D O I
10.1590/0102-672020230002e1731
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Obesity is associated with different medical conditions, such as Walter de BiaseSILVA-NETO1, ClaudemiroQUIRESE1, Eduardo Gu cardiologic, respiratory, gastrointestinal, and genitourinary, and constitutes a severe health problem. AIMS: This study aimed to evaluate the use of intragastric fluid-filled balloon in the reduction of Fabricio FerreiraCOELHO3 , PauloHERMAN3 weight and other measurements related to body composition. METHODS: This is a retrospective, monocentric study involving all patients who opted for the intragastric balloon Spatz (R) placement from January 2018 to July 2019, with fulfillment of inclusion and exclusion criteria. The patients were analyzed after 6 and 12 months after the intragastric fluid-filled balloon placed. RESULTS: A total of RESUMO -Racional: O tratamento de escolha para pacientes com hipertensao portal 121 subjects were included in this study, with 83 (68.6%) females and 38 (31.4%) males. The mean age was 36 esquistossomotica years and height com was sangramento 1.64 +/- 0.09. Weight de meanvarizes ande a stanard desconexadeviatio n was azigo-portal 89.85 +/- 14.65 mais kg, esplenectomia (DAPE) associada a terapia endoscopica. Porem, estudos mostr aumento and body mass index was 33.05 +/- 4.03; body mass index decreased to 29.4 kg/m2 with a m ean weight do calibre das varizes em alguns pacientes durante o seguimento em longo prazo. Objetivo: of 79.83 kg, after 12 months of follow-up. There were statistical differences between body mass index and the 12 months in fat percentage, fat-free mass (kg), visceral fat area, and basal metabolic Avaliar o impacto da DAPE e tratamento endoscopico pos-operatorio no comportamento rate. There was a significant variation according to gender, with males having highest reduction. das varizs esofagicas e recdiva hemorragica, de pacientes esquistosomoticos. Metodos: The percentage of excess weight loss was 46.19, and the total weight loss was 9.24 at the end of theForam study. estudadosCONCLUSIONS:36 pacientesThe studycom demonstratedseguimento a benefsuperiorit of a cincointragastric anos, f luid-filleddistribuidos balloon emon dois grupos: queda da pressao portal abaixo d 30% e acima de 30% compardos com weight loss after 12 months. At the end of treatme nt, body mass index and the measurements o f calibre das varizes esofagicas no pos-operatorio precoce e tardio alem do indice de recidiva body composition were significantly lower. Men benefited more than women from the treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Initial experience with the intragastric balloon
    Darvich, I
    Navarrete, C
    Gibbons, A
    Reyes, C
    OBESITY SURGERY, 2005, 15 (05) : 729 - 729
  • [32] Intervening with an intragastric balloon to induce weight loss and reverse type 2 diabetes
    Brett, A.
    Fourlanos, S.
    Fetterplace, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 140 - 140
  • [33] Gastric Ulceration and Bleeding with Hemodynamic Instability Caused by an Intragastric Balloon for Weight Loss
    Reed, Larrite
    Edriss, Hawa
    Nugent, Kenneth
    CLINICAL ENDOSCOPY, 2018, 51 (06) : 584 - 586
  • [34] High Risk of Aspiration in Patients With ReShape Intragastric Balloon Weight Loss System
    Burbridge, Mark A.
    Coffman, Clarity
    ANESTHESIA AND ANALGESIA, 2017, 124 (02): : 703 - 703
  • [35] OBALON SWALLOWABLE INTRAGASTRIC BALLOON: NEW NON INVASIVE WEIGHT LOSS DEVICE
    Genco, A.
    Maselli, R.
    Frangella, F.
    Casella, G.
    Leone, G.
    Redler, A.
    OBESITY SURGERY, 2014, 24 (08) : 1170 - 1170
  • [36] EFFICIENCY OF INTRAGASTRIC BALLOON AS AN AUXILIARY METHOD TO WEIGHT LOSS: ANALYSIS OF 2002 PATIENTS
    Sander, B. Q.
    Fittipaldi-Fernandez, R. J.
    Scarparo, J. I.
    Galvao Neto, M.
    Nunes, G. C.
    OBESITY SURGERY, 2014, 24 (08) : 1304 - 1304
  • [37] The effect of intragastric balloon placement on weight loss and type 2 diabetes control
    Chan, A. O. O.
    Chow, W. S.
    Lam, K. F.
    Hsu, A.
    Hung, I.
    Chan, P.
    But, D.
    Seto, W. K.
    Lam, K. S. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (01) : 162 - 164
  • [38] Intragastric balloon: evolution of a multidisciplinary clinical treatment in weight loss and waist circumference
    Comparotto, Hugo
    Dantas, Samara
    Hellbrugge, Alessandra
    Navarro, Francisco
    Donatto, Felipe
    Ornellas, Fabio Henrique
    RBONE-REVISTA BRASILEIRA DE OBESIDADE NUTRICAO E EMAGRECIMENTO, 2014, 8 (45): : 79 - 86
  • [39] Lack of efficacy of dual intragastric balloon therapy on weight loss and patient dissatisfaction
    Lew, David
    Thampy, Chelsea
    Hawasli, Abdelkader
    AMERICAN JOURNAL OF SURGERY, 2021, 221 (03): : 581 - 584
  • [40] Life Threatening Gastrointestinal Bleeding Following Intragastric Balloon Placement for Weight Loss
    Edriss, H.
    Nugent, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197